A systematic review of outcomes reported in randomized controlled trials involving people with patellar dislocations.

IF 3.1 Q1 ORTHOPEDICS
Colin P Forde, Crispin Mortimer, Toby O Smith, Matthew L Costa, Jonathan A Cook, Elizabeth Tutton, Georgina Wistow, Paul Minty, David J Keene
{"title":"A systematic review of outcomes reported in randomized controlled trials involving people with patellar dislocations.","authors":"Colin P Forde, Crispin Mortimer, Toby O Smith, Matthew L Costa, Jonathan A Cook, Elizabeth Tutton, Georgina Wistow, Paul Minty, David J Keene","doi":"10.1302/2633-1462.69.BJO-2025-0045.R1","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>The primary aims were to determine what outcome domains, outcome measurement instruments, and outcome measurement timepoints are reported in randomized controlled trials (RCTs) involving people with patellar dislocations. The secondary aims were to determine what primary outcomes were used and how a recurrent patellar dislocation was defined when this was used as an outcome.</p><p><strong>Methods: </strong>We searched MEDLINE, Embase, CINAHL, the Cochrane Database of Controlled Trials, and trial registries (last search: January 2024) for RCTs evaluating treatments for people with a patellar dislocation irrespective of age or sex. We identified the unique outcomes in included studies and mapped these onto the World Health Organization's International Classification of Functioning, Disability and Health (WHO ICF) framework to identify the measured domains. We synthesized results into tables, figures, and text. A critical appraisal of included studies was not required for this systematic review.</p><p><strong>Results: </strong>From the 70 included studies, we identified 141 unique outcomes. The most commonly used unique outcome was a recurrent ipsilateral patellar dislocation (used in 55 studies), but only 17/55 studies (31%) reported how this was defined (i.e. the criteria required for a recurrent ipsilateral patellar dislocation event to be recorded). Unique outcomes mapped onto 66 second-level domains of the WHO ICF framework, and 56% (593/1,052) in the 'activities and participation' domain. Included studies used 42 different patient-reported outcome measures (PROMs), most commonly the Kujala Patellofemoral Score (71%, 50/70 studies), but 28 PROMs (60%) were used only once. In all, 31 different primary outcomes were identified from 47 included studies, with 14 primary outcomes (45%) used only once among included studies. The Kujala Patellofemoral Score was also the most common primary outcome (38%, 18/47 studies). Outcome measurement timepoints varied, but the most common timeframe for primary outcome measurement was > one to three years (46%, 16/35 studies that provided data).</p><p><strong>Conclusion: </strong>The variability in the outcome domains, PROMs, and primary outcomes measured in RCTs evaluating patellar dislocation treatments highlights that a core outcome set is needed. This process is underway and is being informed by this systematic review's findings.</p>","PeriodicalId":34103,"journal":{"name":"Bone & Joint Open","volume":"6 9","pages":"1031-1043"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12408121/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bone & Joint Open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1302/2633-1462.69.BJO-2025-0045.R1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Aims: The primary aims were to determine what outcome domains, outcome measurement instruments, and outcome measurement timepoints are reported in randomized controlled trials (RCTs) involving people with patellar dislocations. The secondary aims were to determine what primary outcomes were used and how a recurrent patellar dislocation was defined when this was used as an outcome.

Methods: We searched MEDLINE, Embase, CINAHL, the Cochrane Database of Controlled Trials, and trial registries (last search: January 2024) for RCTs evaluating treatments for people with a patellar dislocation irrespective of age or sex. We identified the unique outcomes in included studies and mapped these onto the World Health Organization's International Classification of Functioning, Disability and Health (WHO ICF) framework to identify the measured domains. We synthesized results into tables, figures, and text. A critical appraisal of included studies was not required for this systematic review.

Results: From the 70 included studies, we identified 141 unique outcomes. The most commonly used unique outcome was a recurrent ipsilateral patellar dislocation (used in 55 studies), but only 17/55 studies (31%) reported how this was defined (i.e. the criteria required for a recurrent ipsilateral patellar dislocation event to be recorded). Unique outcomes mapped onto 66 second-level domains of the WHO ICF framework, and 56% (593/1,052) in the 'activities and participation' domain. Included studies used 42 different patient-reported outcome measures (PROMs), most commonly the Kujala Patellofemoral Score (71%, 50/70 studies), but 28 PROMs (60%) were used only once. In all, 31 different primary outcomes were identified from 47 included studies, with 14 primary outcomes (45%) used only once among included studies. The Kujala Patellofemoral Score was also the most common primary outcome (38%, 18/47 studies). Outcome measurement timepoints varied, but the most common timeframe for primary outcome measurement was > one to three years (46%, 16/35 studies that provided data).

Conclusion: The variability in the outcome domains, PROMs, and primary outcomes measured in RCTs evaluating patellar dislocation treatments highlights that a core outcome set is needed. This process is underway and is being informed by this systematic review's findings.

Abstract Image

Abstract Image

Abstract Image

对髌骨脱位患者的随机对照试验结果的系统回顾。
目的:主要目的是确定在涉及髌骨脱位患者的随机对照试验(rct)中报告的结果域、结果测量工具和结果测量时间点。次要目的是确定使用的主要结局,以及复发性髌骨脱位作为结局时如何定义。方法:我们检索MEDLINE、Embase、CINAHL、Cochrane对照试验数据库和试验注册库(最后检索时间:2024年1月),检索评估髌骨脱位患者治疗方法的随机对照试验,而不考虑年龄或性别。我们确定了纳入研究的独特结果,并将其映射到世界卫生组织的国际功能、残疾和健康分类(WHO ICF)框架中,以确定测量的领域。我们将结果合成为表格、图表和文本。本系统综述不需要对纳入的研究进行批判性评价。结果:从纳入的70项研究中,我们确定了141个独特的结果。最常用的独特结局是复发性同侧髌骨脱位(55项研究使用),但只有17/55项研究(31%)报告了如何定义(即记录复发性同侧髌骨脱位事件所需的标准)。独特成果映射到世卫组织ICF框架的66个二级领域,56%(593/ 1052)映射到“活动和参与”领域。纳入的研究使用了42种不同的患者报告结果测量(PROMs),最常见的是Kujala髌股评分(71%,50/70项研究),但28种PROMs(60%)仅使用一次。总的来说,从47个纳入的研究中确定了31个不同的主要结局,其中14个主要结局(45%)在纳入的研究中仅使用一次。Kujala髌股评分也是最常见的主要预后指标(38%,18/47研究)。结果测量时间点各不相同,但主要结果测量最常见的时间范围是1 - 3年(46%,16/35研究提供数据)。结论:在评估髌骨脱位治疗的随机对照试验中测量的结果域、prom和主要结果的可变性强调了需要一个核心结果集。这一过程正在进行中,并根据本系统评价的结果提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bone & Joint Open
Bone & Joint Open ORTHOPEDICS-
CiteScore
5.10
自引率
0.00%
发文量
0
审稿时长
8 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信